Drug details:
Molecular formula: C₁₅H₁₄N₂O₆S₄

Standard name: 2-[4-oxo-2-sulfanylidene-5-[3-(3-sulfopropyl)-1,3-benzothiazol-2-ylidene]-1,3-thiazolidin-3-yl]acetic acid

Curated SMILES: O=C(O)CN1C(=O)/C(=C2/SC3=C(C=CC=C3)N2CCCS(=O)(=O)O)SC1=S

Evidence for compound's anti-virulence activity:

Mycobacterium
Related VFcategory: Exoenzyme
Target: Zmp1
Drug effect: Inhibits the Mycobacterium tuberculosis extracellular zinc metalloprotease 1 (Zmp1) that is essential for phagosome maturation and bacterial intracellular survival.
Max phase: Preclinical (in vitro)
Publication:
Mori M, et al., 2014. Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor. Bioorg Med Chem Lett 24(11):2508-11.